Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jarrod Kaufman

Surgery Brick, NJ Medical Doctor

NPI 1154364073 CMS profile 278487

525 Route 70 East Ste 1B, Brick, NJ 08723

Open in the dashboard

General payments

$473,594

539 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$37,064

1 holding reported · through program year 2025

Research they led as principal investigator

$50,290 paid to institutions, not to them · program years 2020–2021

Through program year 2025, Jarrod Kaufman of Brick, NJ is reported in the CMS Open Payments database as having received $473,594 across 539 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $50,290 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $37,064 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,337 8
2024 General $35,624 47
2023 General $21,749 80
2022 General $176,430 154
2021 General $83,753 107
2020 General $45,026 43
2019 General $109,676 100
2020 Ownership $37,064 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jarrod Kaufman
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Jarrod Kaufman were reported at $1,337. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Jarrod Kaufman Surgery median Middle half National median
2019 $109,676 $253 $82–$1,521 $163
2020 $45,026 $131 $40–$706 $114
2021 $83,753 $168 $50–$904 $132
2022 $176,430 $224 $76–$1,218 $149
2023 $21,749 $253 $82–$1,255 $160
2024 $35,624 $279 $90–$1,381 $164
2025 $1,337 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Musculoskeletal Transplant Foundation Inc. $223,268 136 payments
  2. Innocoll Incorporated $59,868 78 payments
  3. RedDress USA, Inc. $53,802 26 payments
  4. Kerecis Limited $37,247 14 payments
  5. RTI Surgical, Inc $25,246 10 payments
  6. Geistlich Pharma, North America, Inc. $14,078 11 payments
  7. ETS Wound Care LLC $10,077 8 payments
  8. Davol Inc. $8,443 63 payments
  9. FUJIFILM Medical Systems USA, Inc. $8,201 35 payments
  10. Baxter Healthcare $7,781 8 payments
  11. Other $25,582 150 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $353,863 76 payments
  2. Travel and Lodging $59,993 133 payments
  3. Honoraria $33,275 22 payments
  4. Food and Beverage $20,005 300 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,675 3 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $1,000 1 payment
  7. Royalty or License $766 3 payments
  8. Gift $16 1 payment
Products named General payments · program years 2019–2025
  1. XARACOLL Prescription Drug $37,259 37 payments
  2. Kerecis Omega3 SurgiClose $37,108 13 payments
  3. Kerecis Omega3 GraftGuide $32,952 10 payments
  4. Kerecis Omega3 Marigen Wound Care $32,890 8 payments
  5. Kerecis Omega3 Marigen Wound Care $28,735 5 payments
  6. Kerecis Omega3 Marigen Wound Care $28,735 5 payments
  7. FORTIVA PORCINE DERMIS $25,079 8 payments
  8. XARACOLL Pain $21,446 37 payments
  9. Derma Gide $11,101 3 payments
  10. MIRRAGEN ADVANCED WOUND MATRIX $10,023 6 payments
  11. Other $84,507 290 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

142

Median for General Surgery: 59

Drug cost

$1,070

Median for General Surgery: $393

Branded share of claims

29.6%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sucralfate Generic 14 $366
Mupirocin Generic 61 $335
Ammonium Lactate Generic 14 $182
Doxycycline Hyclate Generic 11 $115
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 42 $71

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$710,082

Medicare's payments for the services billed

Medicare patients

222

Average age 73

Services billed

1,263

77 women, 145 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Ischemic heart disease 42%
Diabetes 32%
Cancer 22%
Atrial fibrillation 18%
Chronic kidney disease 18%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

539 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record